Antibiotice S.A. (BVB:ATB)

Antibiotice Income Statement

Financials in millions RON. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	648.05	686.13	614.16	497.5	376.76	346.78
Other Revenue	0.91	2.57	1.12	7.5	2.07	0.45
Revenue	648.96	688.7	615.29	505	378.83	347.22
Revenue Growth (YoY)	-1.36%	11.93%	21.84%	33.31%	9.10%	-12.13%
Cost of Revenue	245.62	254.42	232.64	187.45	146.97	109.56
Gross Profit	403.34	434.28	382.65	317.55	231.86	237.66
Selling, General & Admin	182.46	171.14	161.69	130.53	125.92	118.01
Other Operating Expenses	97.71	110.9	95.66	91.94	47.57	60.43
Operating Expenses	331.55	327.09	285.23	244.73	197.61	200.24
Operating Income	71.79	107.19	97.42	72.81	34.25	37.42
Interest Expense	-4.51	-4.54	-4.15	-3.59	-3.52	-4.93
Interest & Investment Income	0	0	0	0	0	0
Currency Exchange Gain (Loss)	-4.74	0.26	-0.95	-0.8	-0.22	-3.72
Other Non Operating Income (Expenses)	0.2	0.04	0.08	-0.18	-0.21	-0.44
EBT Excluding Unusual Items	62.74	102.95	92.42	68.25	30.3	28.33
Gain (Loss) on Sale of Assets	-	0.16	0	0.1	-	-
Asset Writedown	-	-	-0.9	-3.04	-	-
Pretax Income	62.74	103.11	91.52	65.31	30.3	28.33
Income Tax Expense	5.84	0.91	10.44	13.84	0.36	1.94
Net Income	56.9	102.2	81.09	51.47	29.94	26.39
Net Income to Common	56.9	102.2	81.09	51.47	29.94	26.39
Net Income Growth	-38.34%	26.04%	57.54%	71.92%	13.46%	-14.39%
Shares Outstanding (Basic)	671	671	671	671	671	671
Shares Outstanding (Diluted)	671	671	671	671	671	671
EPS (Basic)	0.08	0.15	0.12	0.08	0.04	0.04
EPS (Diluted)	0.08	0.15	0.12	0.08	0.04	0.04
EPS Growth	-38.36%	26.04%	57.54%	71.92%	13.46%	-14.39%
Free Cash Flow	-88.7	-3.63	39.43	78.09	15.39	46.06
Free Cash Flow Per Share	-0.13	-0.01	0.06	0.12	0.02	0.07
Dividend Per Share	0.021	0.021	0.083	0.008	0.003	0.003
Dividend Growth	-75.21%	-75.21%	946.74%	147.72%	-3.27%	-88.94%
Gross Margin	62.15%	63.06%	62.19%	62.88%	61.20%	68.45%
Operating Margin	11.06%	15.56%	15.83%	14.42%	9.04%	10.78%
Profit Margin	8.77%	14.84%	13.18%	10.19%	7.90%	7.60%
Free Cash Flow Margin	-13.67%	-0.53%	6.41%	15.46%	4.06%	13.27%
EBITDA	138.26	152.24	125.35	95.38	58.68	59.52
EBITDA Margin	21.30%	22.11%	20.37%	18.89%	15.49%	17.14%
D&A For EBITDA	66.47	45.06	27.93	22.57	24.43	22.1
EBIT	71.79	107.19	97.42	72.81	34.25	37.42
EBIT Margin	11.06%	15.56%	15.83%	14.42%	9.04%	10.78%
Effective Tax Rate	9.31%	0.88%	11.40%	21.19%	1.20%	6.85%
Advertising Expenses	-	-	-	-	11.01	8.69

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.